Although derived from two different animal models and differing in the PAR2 expressing compartment (stromal vs. tumor cell), the data nevertheless suggest that both TGF-β/ALK5 and PAR2 inhibited primary tumor growth but promoted metastatic dissemination. The gene discussed is F2RL1; the disease is neoplasm.